Oxford BioDynamics Plc (OBD.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Oxford BioDynamics Plc
Address
3140 Rowan Place
Oxford, OX OX4 2WB
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 1865 518 910
Sector
Healthcare
Industry
Biotechnology
Employees
37
First IPO Date
December 06, 2016
Key Executives
| Name | Title | Pay | Year Born |
| Richard Compton | Chief Executive Officer | 0 | N/A |
| Paul Leslie Stockdale | Chief Financial Officer & Executive Director | 211,000 | 1975 |
| Alexandre Akoulitchev Ma | Chief Scientific Officer & Executive Director | 244,000 | 1962 |
| Iain Gladstone Ross | Executive Chairman | 286,500 | 1954 |
| Ewan Hunter | Chief Data Officer | 0 | N/A |
| David Blum | Senior Vice President of Marketing | 0 | N/A |
| T. Demain | Company Secretary | 0 | N/A |
Description
Oxford BioDynamics Plc operates as a biotechnology firm that specializes in identifying and advancing biomarkers, primarily for the pharmaceutical and biotechnology sectors across global markets, including the United States. Its flagship offering is EpiSwitch, an exclusive technological platform employed for discovering, assessing, validating, and tracking epigenetic biomarkers, specifically referred to as chromosome conformation signatures. These are crucial for developing medical diagnostic kits, predicting disease onset, aiding in diagnosis, and informing therapeutic strategies. The company's key products encompass the EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic tool for forecasting patient responses to checkpoint inhibitor immunotherapy; the EpiSwitch CST (Covid Severity Test), a sophisticated blood test designed to predict the severity of COVID-19 in adults; and the EpiSwitch Explorer Array Kit, which enables high-resolution 3D genome analysis and novel biomarker discovery. Established in 2007, Oxford BioDynamics Plc maintains its headquarters in Oxford, United Kingdom.
